5月9日，截至港股收盘，恒生指数上涨0.4%，报22867.74点。天大药业（00455.HK）收报0.162港元/ 股，上涨8.0%，成交量2000股，成交额326港元，振幅0.67%。 行业估值方面，药品及生物科技行业市盈率（TTM）平均值为5.44倍，行业中值4.53倍。天大药业市盈 率-5.26倍，行业排名第125位；其他精优药业（00858.HK）为0.72倍、金斯瑞生物科技（01548.HK）为 1.05倍、东瑞制药（02348.HK）为2.86倍、大健康国际（02211.HK）为4.14倍、帝王国际投资 （00928.HK）为4.28倍。 资料显示，天大药业有限公司(简称天大药业,香港联交所上市公司,股份代号0455)以发展中医药产业为 基础,发展创新药物和医疗科技,发展优质医疗和保健服务,致力于成为药品研制、医疗科技、中医诊疗、 健康管理领域具有市场竞争力和核心价值链的医药企业。天大药业从中医、中药、中医药智能三大方面 打造中医药全产业链,建立控制中药材品质的"天大标准",创办新型中医馆—天大馆。作为中医诊疗及健 康管理平台,天大馆秉承"上医治未病"的中医理念,恪守"中病即止,以人为本"的治疗 ...

Annual Report 2024 CONTENTS 目錄 | 2 | Corporate Information | 公司資料 | | --- | --- | --- | | 5 | Corporate Structure | 企業架構 | | 8 | Biographical Details of Directors | 董事簡歷 | | 11 | Report of the Chairman | 董事長報告 | | 13 | Management Discussion and Analysis | 管理層討論與分析 | | 22 | Corporate Governance Report | 企業管治報告 | | 44 | Report of the Directors | 董事會報告 | | 57 | Independent Auditor's Report | 獨立核數師報告 | | 64 | Consolidated Statement of Profit or Loss and | 綜合損益及其它全面收益表 | | | Other Comprehensive Income | | | 66 | ...

（以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。） 来源：金融界 截至4月10日收盘，天大药业（00455.HK）报0.136港元，较上个交易日下跌12.26%，当日盘中最低价 触及0.135港元，创近一年新低。 资金流向方面，当日主力流入0.000万港元，流出0.297万港元，净流出0.30万港元。 天大药业有限公司(简称天大药业,香港联交所上市公司,股份代号0455)以发展中医药产业为基础,发展创 新药物和医疗科技,发展优质医疗和保健服务,致力于成为药品研制、医疗科技、中医诊疗、健康管理领 域具有市场竞争力和核心价值链的医药企业。天大药业从中医、中药、中医药智能三大方面打造中医药 全产业链,建立控制中药材品质的"天大标准",创办新型中医馆—天大馆。作为中医诊疗及健康管理平台, 天大馆秉承"上医治未病"的中医理念,恪守"中病即止,以人为本"的治疗准则,立足粤港澳大湾区,布局全国 全球,努力发展成为中医馆第一品牌;并充分利用互联网资讯技术、大数据、人工智能及其它创新科技,搭 建"云上天大馆",实现中医药服务线上线下相互融合、远端诊疗及专家会诊,为民众提供优质、便捷、全 面的中医 ...

年報 2023 19 MANAGEMENT DISCUSSION AND ANALYSIS 管理層討論與分析 TDMall growing with innovative business model to promote TCM culture The Group created the new type Chinese medicine clinic brand "TDMall", with the core positioning of "specialist treatments and specialized services, effectiveness and efficacy, combination of recovery and health-preservation, and harmony between nature and mankind". Since the opening of its first flagship in 2019, TDMall continuously improved its medical system, operation system, marke ...

Annual Report 2022 (For The Nine Months Ended 31 December 2022) CONTENTS 目錄 2 Corporate Information 公司資料 5 Corporate Structure 企業架構 8 Biographical Details of Directors 董事簡歷 11 Report of the Chairman 董事長報告 13 Management Discussion and Analysis 管理層討論與分析 21 Corporate Governance Report 企業管治報告 44 Report of the Directors 董事會報告 58 Independent Auditor’s Report 獨立核數師報告 65 Consolidated Statement of Profit or Loss and 綜合損益及其它全面收益表 Other Comprehensive Income 67 Consolidated Statement of Financial Position 綜合財務狀況表 69 Co ...

天大藥業有限公司 TIANDA PHARMACEUTICALS LIMITED 股份代號 Stock Code: 00455 ( 於開曼群島註冊成立之公司 ) ( Incorporated in the Cayman Islands with limited Tability ) Interim Report 2022 01 CONTENTS 目錄 2 Corporate Information 3 Management Discussion and Analysis 9 Disclosure of Interests and Other Information 12 公司資料 13 管理層討論與分析 19 權益披露及其它資料 22 Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income 簡明綜合損益及其它全面收益表 24 Condensed Consolidated Statement of Financial Position 簡明綜合財務狀況表 26 Condensed Consolidated ...

Rep 天大藥業有限公司 TIANDA PHARMACEUTICALS LIMITED 股份代號 Stock Code: 00455（於開曼群島註冊成立之公司） (Incorporated in the Cayman Islands with limited liability) Annual Report 2022 CONTENTS 目錄 | --- | --- | --- | |-------|-------|--------------------------| | | | | | | 2 Corporate Information | 公司資料 | | | 5 Corporate Structure | 企業架構 | | | 8 Biographical Details of Directors | 董事簡歷 | | | 12 Report of the Chairman | 董事長報告 | | | 14 Management Discussion and Analysis | 管理層討論與分析 | | | 19 Corporate Governance Report | 企業管治報告 | | | 3 ...

天大藥業有限公司 TIANDA PHARMACEUTICALS LIMITED 股份代號 Stock Code: 00455 ( 於開曼群島註冊成立之公司 ) ( Incorporated in the Cayman Islands with limited Tability ) Interim Report 2021 01 CONTENTS 目錄 2 Corporate Information 3 Management Discussion and Analysis 8 Disclosure of Interests and Other Information 11 公司資料 12 管理層討論與分析 17 權益披露及其它資料 20 Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income 簡明綜合損益及其它全面收益表 22 Condensed Consolidated Statement of Financial Position 簡明綜合財務狀況表 24 Condensed Consolidated ...

Rep 天大藥業有限公司 TIANDA PHARMACEUTICALS LIMITED 股份代號 Stock Code: 00455（於開曼群島註冊成立之公司） (Incorporated in the Cayman Islands with limited liability) Annual Report 2021 CONTENTS 目錄 | --- | --- | --- | |-------|-------|--------------------------| | | | | | | 2 Corporate Information | 公司資料 | | | 5 Corporate Structure | 企業架構 | | | 8 Biographical Details of Directors | 董事簡歷 | | | 13 Report of the Chairman | 董事長報告 | | | 16 Management Discussion and Analysis | 管理層討論與分析 | | | 24 Corporate Governance Report | 企業管治報告 | | | 4 ...

Re 天 大 藥 業 有 限 公 司 TIANDA PHARMACEUTICALS LIMITED 股份代號 Stock Code: 00455 ( 於開曼群島註冊成立之公司 ) ( Incorporated in the Cayman Islands with limited Kability } Interim Report 2020 01 CONTENTS 目錄 | --- | --- | |-------|-----------------------------------------------------------------------------------------------------------------| | | | | | | | 2 | Corporate Information | | 3 | Highlights | | 4 | Management Discussion and Analysis | | 9 | Disclosure of Interests and Other Information | | 12 | 公司資料 | | 13 | 摘要 | | 14 ...